ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Brain Metastases From HER2 and Breast Cancer|Advanced HER2-positive Breast Cancer
Interventions: DRUG: ARRY-380 Twice Daily Dosage|DRUG: ARRY-380 Once Daily|DRUG: Trastuzumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Array BioPharma|Breast Cancer Research Foundation